Authors: MacKenzie, RG Franssen, E Wong, R Sawka, C Berinstein, N Cowan, DH Senn, J Poldre, P

Citation: Rg. Mackenzie et al., Risk-adapted therapy for clinical stage I-II Hodgkin's disease: 7-year results of radiotherapy alone for low-risk disease, and ABVD and radiotherapy for high-risk disease, CL ONCOL-UK, 12(5), 2000, pp. 278-288

Authors: MacKenzie, RG Franssen, E Balogh, JM Gilbert, RW Birt, D Davidson, J

Citation: Rg. Mackenzie et al., Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: A comparison limited to patients eligible for surgery, INT J RAD O, 47(1), 2000, pp. 65-71

Authors: Akunne, HC Zoski, KT Davis, MD Cooke, LW Meltzer, LT Whetzel, SZ Shih, YH Wustrow, DJ Wise, LD MacKenzie, RG Georgic, LM Heffner, TG Pugsley, TA

Citation: Hc. Akunne et al., PD 158771, a potential antipsychotic agent with D-2/D-3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects, NEUROPHARM, 39(7), 2000, pp. 1197-1210

Authors: Yamada, Y Ackerman, I Franssen, E MacKenzie, RG Thomas, G

Citation: Y. Yamada et al., Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer?, INT J RAD O, 44(1), 1999, pp. 99-104

Authors: Ho, GY MacKenzie, RG

Citation: Gy. Ho et Rg. Mackenzie, Functional characterization of mutations in melanocortin-4 receptor associated with human obesity, J BIOL CHEM, 274(50), 1999, pp. 35816-35822

Authors: MacKenzie, RG Fisher, MM

Citation: Rg. Mackenzie et Mm. Fisher, The Society for Adolescent Medicine's role in promoting education, J ADOLES H, 23(6), 1998, pp. 135-142